Germline Lymphoma-Predisposing Variants: Influence on Age at Diagnosis and Survival Outcomes in Pediatric Patients
Highlights
- Identification of germline lymphoma-predisposing variants correlates with significantly earlier age of cancer diagnosis in pediatric patients.
- Such variants impact survival outcomes variably depending on specific genetic alterations and lymphoma subtypes.
- Integration of germline genetic testing into pediatric lymphoma care may facilitate risk stratification and tailored therapy.
- Current evidence underscores the need for further research into mechanistic pathways linking germline mutations with lymphoma pathogenesis and prognosis.
Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.